972 results on '"Aigner, Clemens"'
Search Results
2. Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial
3. C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy
4. Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer
5. C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer
6. Evolutionary trajectories of small cell lung cancer under therapy
7. Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms
8. Correction: ASO Visual Abstract: The Prognostic Role of the Number of Involved Structures in Thymic Epithelial Tumors: Results from the ESTS Database
9. Correction: ASO Author Reflections: The Number of Involved Structures is a Promising Prognostic Factor in Thymic Epithelial Tumors
10. Correction: The Prognostic Role of the Number of Involved Structures in Thymic Epithelial Tumors: Results from the ESTS Database
11. ASO Visual Abstract: The Prognostic Role of the Number of Involved Structures in Thymic Epithelial Tumors: Results from the ESTS Database
12. ASO Author Reflections: The Number of Involved Structures is a Promising Prognostic Factor in Thymic Epithelial Tumors
13. Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting
14. Chirurgie des alten Menschen – Thoraxchirurgie
15. Lungentransplantation
16. Early Detection of Lung Cancer Using Small RNAs
17. Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma
18. Potential subtype-specific therapeutic approaches in small cell lung cancer
19. Neoadjuvant immune-checkpoint inhibitors in lung cancer - a primer for radiologists
20. TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy
21. Preoperative PET-SUVmax and volume based PET parameters of the primary tumor fail to predict nodal upstaging in early-stage lung cancer
22. Lungentransplantation
23. Side Effects of Surgical Therapy for Non-Small Cell Lung Cancer: Prevention and Treatment
24. Prognostic Implications of68Ga-FAPI-46 PET/CT–Derived Parameters on Overall Survival in Various Types of Solid Tumors
25. Prognostic Factors for Leiomyosarcoma with Isolated Metastases to the Lungs: Impact of Metastasectomy
26. Mediastinaler Pseudotumor – nekrotisierende und sklerosierende Mediastinitis mit Pseudomembranen
27. Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm
28. Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications
29. Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT
30. Reversible occlusion of the pulmonary vasculature by transarterial embolisation with degradable starch microspheres: preclinical assessment in a human isolated lung perfusion model
31. Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment
32. Fibroblast Activation Protein-Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial.
33. Prognostic Implications of 68Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors.
34. Diagnostic Accuracy of 68Ga-FAPI Versus 18F-FDG PET in Patients with Various Malignancies.
35. Cognitive Function After Lung Transplantation
36. Alternative venous access sites for dual-lumen extracorporeal membrane oxygenation cannulation
37. Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease
38. Transcriptional profiling sheds light on the fibrotic aspects of idiopathic subglottic tracheal stenosis
39. Diagnostic Accuracy of68Ga-FAPI Versus18F-FDG PET in Patients with Various Malignancies
40. Indications and Contraindications in Lung Transplantation
41. Bridge to Lung Transplantation
42. Impact of EBUS-TBNA in addition to [18F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
43. Lungentransplantation
44. Lobar lung transplantation from deceased donors: A systematic review.
45. The ESTS-AIR database-initial results of a multi-institutional database on airway surgery
46. Transcriptional profiling sheds light on the fibrotic aspects of idiopathic subglottic tracheal stenosis.
47. The impact of previous endoscopic treatments on functional outcome after cricotracheal resection.
48. The Incidence of Distant Metastases in Patients with Pleural Mesothelioma Screened for a Multimodal Approach: How Much Staging Do We Really Need?
49. Resectable non-stage IV nonsmall cell lung cancer: the surgical perspective
50. Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and Eosinophils
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.